Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

Correlation of Relative Afferent Pupillary Defect (RAPD) pupillograph measurements with optic nerve function and structure in optic neuropathies

Stefania Bianchi Marzoli; Gemma Tremolada; Anna Merico; Gabriella Cammmarata; Paola Ciasca

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4112. doi:

ARVO Annual Meeting Abstract April 2009

Increased Clonogenic Potential of Endothelial Progenitor Cells (EPCs) in Type 1 Diabetic Patients with Early Non Proliferative Diabetic Retinopathy

G. Tremolada; R. Lattanzio; A. Maestroni; D. Gabellini; M. Pastore; R. Bonfanti; A. Palini; P. Rama; M. Lorenzi; G. Zerbini

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4983. doi:

ARVO Annual Meeting Abstract May 2006

Correlation Between Glycated Hemoglobin (HbA1c) and Number of Endothelial Progenitor Cells (EPCs) Colony–Forming Units (CFUs) in Patients With Type 1 Diabetes and Proliferative Diabetic Retinopathy (PDR)

G. Tremolada; R. Lattanzio; G. Zerbini; A. Ramoni; V. Asnaghi; G. Mazzolari; M.R. Pastore; R. Brancato

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3840. doi:

ARVO Annual Meeting Abstract May 2006

Baseline Visual Acuity as a Short Term Prognostic Factor for the Treatment of Chronic Diabetic Macular Edema With Intravitreal Triamcinolone Acetonide (IVTA)

A. Ramoni; R. Lattanzio; G. Tremolada; E. Bruschi; F. Legorini; U. Introini; R. Brancato

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3864. doi:

ARVO Annual Meeting Abstract May 2005

Diabetic Macular Edema : Juxtascleral (JS) versus Intravitreal (IV) Triamcinolone Acetonide (TA) Injections

R. Brancato; R. Lattanzio; G. Tremolada; F. Scotti; S. Donati; L. Pierro; U. Introini; G. Modorati; E. Miserocchi

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):281. doi:

ARVO Annual Meeting Abstract May 2005

Efficacy of Intravitreal Triamcinolone Acetonide (IVTA) Injections in Chronic Macular Edema in Diabetic Retinopathy (DR) vs Central Retinal Vein Occlusion (CRVO)

R. Lattanzio; A. Ramoni; E. Bruschi; G. Tremolada; F. Scotti; S. Donati; U. Introini; L. Pierro; R. Brancato

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1430. doi:

ARVO Annual Meeting Abstract May 2005

Exudative Age–Related Macular Degeneration Findings Evaluated With Optical Coherence Tomography/Scanning Laser Ophthalmoscope (OCT/SLO)

G. Tremolada; L. Pierro; R. Brancato; U. Introini; S. Donati; S. Di Simplicio

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1584. doi:

ARVO Annual Meeting Abstract May 2004

Evaluation of Artifacts in the Use of OCT

R. Brancato; L. Pierro; G. Tremolada

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2983. doi:

ARVO Annual Meeting Abstract May 2003

OCT and FA in the Follow-Up of PDT Treatment of CNV in Myopic Patients

R. Brancato; L. Pierro; U. Introini; S. Morlino; G. Tremolada; G. Calori

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1103. doi:

ARVO Annual Meeting Abstract May 2003

Epiretinal Membranes: Optical Coherence Tomography and Ultrasound Findings

L.M. Pierro; G. Tremolada; S. Morlino; G. Calori; R. Brancato

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3634. doi:

Advertisement